Working its way through a CRL on lead drug, Supernus taps $150M loan
As Rockville, MA-based Supernus works its way back to the FDA’s good graces with a lead Parkinson’s drug, it is tapping into a $150 million …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
